PFE vs V: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
VS
Visa Inc. · Financial Services
$304.36
+37.7% upside to fair value
High Conviction
Grade A-
QuantHub Verdict
V has more upside to fair value
(+37.7%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
V |
| Current Price |
$26.91 |
$304.36 |
| Fair Value Estimate |
$35.00 |
$419.00 |
| Upside to Fair Value |
+30.1%
|
+37.7%
|
| Market Cap |
$153.0B |
$586.8B |
| Forward P/E |
9.5x
|
23.7x
|
| EV / EBITDA |
13.8x
|
22.3x
|
| Price / Sales |
2.4x
|
14.2x
|
| Price / FCF |
16.8x
|
25.6x
|
| Revenue Growth YoY |
-1.6%
|
+11.3%
|
| Gross Margin |
70.3%
|
81.08%
|
| Operating Margin |
24.7%
|
59.18%
|
| Return on Equity |
9.0%
|
54.22%
|
| Dividend Yield |
6.4% |
0.83% |
| FCF Yield |
5.9%
|
3.91%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Visa is the world's dominant payment network with $40B in net revenue (FY2025), 50%+ net margins, and a capital-light toll-booth model processing $14.2T in annual payment volume across 257.5B transactions. The business compounds at 10-12% revenue CAGR with operating leverage pushing EPS growth to 12-15% over a cycle, funded by $21.6B in annual free cash flow against only $1.5B in capex. At 28.0x …
Accumulation Zones
| Metric |
PFE |
V |
| Zone Low |
$25.00 |
$265.00 |
| Zone High |
$29.00 |
$300.00 |
| In Buy Zone? |
Yes
|
No
|